Image

Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Recruiting
20 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are:

What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.

Eligibility

Inclusion Criteria:

  • Patients with acute cerebrovascular disease, within 1 month after acute attack.
  • Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment.
  • Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans.
  • Aged over 20 years old

Exclusion Criteria:

  • Patients with atrial fibrillation/arrhythmia.
  • Within 2 weeks after cardiac catheterization or arterial puncture at the femoral artery puncture site.
  • Decompensated heart failure (NYHA class 3 or 4).
  • Left ventricular ejection fraction (EF) < 30%.
  • Moderate or severe aortic regurgitation.
  • Persistent and uncontrolled hypertension (blood pressure persistently >160/100 mmHg).
  • Bleeding tendency.
  • Active phlebitis/venous disease of the lower extremities.
  • Severe vascular occlusive disease of the lower extremities.
  • The presence of documented aortic aneurysm/dissection requiring surgical repair.
  • Pregnancy.

Study details
    Cerebrovascular Accident (CVA)

NCT06711003

China Medical University Hospital

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.